Item Type | Name |
Academic Article
|
Structural stability of disulfide mutants of basic pancreatic trypsin inhibitor: a molecular dynamics study.
|
Academic Article
|
The role of protein-solvent interactions in protein unfolding.
|
Academic Article
|
Accessibility and order of water sites in and around proteins: A crystallographic time-averaging study.
|
Academic Article
|
Crystal structure of human thymidylate synthase: a structural mechanism for guiding substrates into the active site.
|
Academic Article
|
Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance.
|
Academic Article
|
Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.
|
Academic Article
|
Cooperative fluctuations of unliganded and substrate-bound HIV-1 protease: a structure-based analysis on a variety of conformations from crystallography and molecular dynamics simulations.
|
Academic Article
|
PTEN enters the nucleus by diffusion.
|
Academic Article
|
Crystallization of human thymidylate synthase.
|
Academic Article
|
How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease.
|
Academic Article
|
Competition between Ski and CREB-binding protein for binding to Smad proteins in transforming growth factor-beta signaling.
|
Academic Article
|
Contribution of Ser386 and Ser396 to activation of interferon regulatory factor 3.
|
Academic Article
|
Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5.
|
Academic Article
|
Toward the design of mutation-resistant enzyme inhibitors: further evaluation of the substrate envelope hypothesis.
|
Academic Article
|
Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces.
|
Academic Article
|
Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease.
|
Academic Article
|
Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sites.
|
Academic Article
|
The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.
|
Academic Article
|
Molecular mechanisms of viral and host cell substrate recognition by hepatitis C virus NS3/4A protease.
|
Academic Article
|
Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes.
|
Academic Article
|
Hydrophobic core flexibility modulates enzyme activity in HIV-1 protease.
|
Academic Article
|
Design, synthesis, and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance.
|
Academic Article
|
Extreme entropy-enthalpy compensation in a drug-resistant variant of HIV-1 protease.
|
Academic Article
|
The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors.
|
Academic Article
|
Nitric oxide-mediated inhibition of Hdm2-p53 binding.
|
Academic Article
|
Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy.
|
Academic Article
|
Structure-based prediction of potential binding and nonbinding peptides to HIV-1 protease.
|
Academic Article
|
Promise of advances in simulation methods for protein crystallography: implicit solvent models, time-averaging refinement, and quantum mechanical modeling.
|
Academic Article
|
Simultaneous refinement of the structure of BPTI against NMR data measured in solution and X-ray diffraction data measured in single crystals.
|
Academic Article
|
Exploring the role of the solvent in the denaturation of a protein: a molecular dynamics study of the DNA binding domain of the 434 repressor.
|
Academic Article
|
Expression, purification, and characterization of thymidylate synthase from Lactococcus lactis.
|
Academic Article
|
Inclusion of solvation free energy with molecular mechanics energy: alanyl dipeptide as a test case.
|
Academic Article
|
Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease.
|
Academic Article
|
Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance.
|
Academic Article
|
Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate.
|
Academic Article
|
Substrate specificity in HIV-1 protease by a biased sequence search method.
|
Academic Article
|
Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity.
|
Academic Article
|
Hydrophobic sliding: a possible mechanism for drug resistance in human immunodeficiency virus type 1 protease.
|
Academic Article
|
Prediction of homologous protein structures based on conformational searches and energetics.
|
Academic Article
|
Crystal structure of lysine sulfonamide inhibitor reveals the displacement of the conserved flap water molecule in human immunodeficiency virus type 1 protease.
|
Academic Article
|
Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity.
|
Academic Article
|
Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in complex with the substrate p1-p6.
|
Academic Article
|
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance.
|
Academic Article
|
Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance.
|
Academic Article
|
Rationale for more diverse inhibitors in competition with substrates in HIV-1 protease.
|
Academic Article
|
Therapeutic targeting of C-terminal binding protein in human cancer.
|
Academic Article
|
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding.
|
Academic Article
|
Structural, kinetic, and thermodynamic studies of specificity designed HIV-1 protease.
|
Academic Article
|
Mass spectrometry tools for analysis of intermolecular interactions.
|
Academic Article
|
Structural insights into neuronal K+ channel-calmodulin complexes.
|
Academic Article
|
Structural and thermodynamic basis of amprenavir/darunavir and atazanavir resistance in HIV-1 protease with mutations at residue 50.
|
Academic Article
|
Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.
|
Concept
|
Protein Binding
|
Concept
|
Protein Transport
|
Concept
|
Protein Folding
|
Concept
|
Protein Processing, Post-Translational
|
Concept
|
Tumor Suppressor Protein p53
|
Concept
|
Protein Interaction Mapping
|
Concept
|
Protein Interaction Domains and Motifs
|
Concept
|
Protein Denaturation
|
Concept
|
CREB-Binding Protein
|
Concept
|
Protein Structure, Secondary
|
Concept
|
Protein Structure, Tertiary
|
Concept
|
Protein Multimerization
|
Concept
|
Protein Structure, Quaternary
|
Concept
|
Structural Homology, Protein
|
Concept
|
Protein Conformation
|
Concept
|
Protein Engineering
|
Academic Article
|
A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid.
|
Academic Article
|
Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance.
|
Academic Article
|
The interdomain interface in bifunctional enzyme protein 3/4A (NS3/4A) regulates protease and helicase activities.
|
Academic Article
|
Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.
|
Academic Article
|
HIV-1 protease-substrate coevolution in nelfinavir resistance.
|
Academic Article
|
Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease.
|
Academic Article
|
A computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif.
|
Academic Article
|
A novel Geobacteraceae-specific outer membrane protein J (OmpJ) is essential for electron transport to Fe(III) and Mn(IV) oxides in Geobacter sulfurreducens.
|
Academic Article
|
Investigation of protein unfolding and stability by computer simulation.
|
Academic Article
|
The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization.
|
Academic Article
|
Structure-guided design of a high affinity inhibitor to human CtBP.
|
Academic Article
|
Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G.
|
Academic Article
|
A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro.
|
Academic Article
|
Structural basis for mutation-induced destabilization of profilin 1 in ALS.
|
Academic Article
|
Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions.
|
Academic Article
|
Molecular Basis for Differential Patterns of Drug Resistance in Influenza N1 and N2 Neuraminidase.
|
Academic Article
|
Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
|
Academic Article
|
Interdependence of Inhibitor Recognition in HIV-1 Protease.
|
Academic Article
|
Structural Determination of the Broadly Reactive Anti-IGHV1-69 Anti-idiotypic Antibody G6 and Its Idiotope.
|
Academic Article
|
Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions.
|
Academic Article
|
Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.
|
Academic Article
|
Molecular Mechanism of Resistance in a Clinically Significant Double-Mutant Variant of HCV NS3/4A Protease.
|
Academic Article
|
Probing Structural Changes among Analogous Inhibitor-Bound Forms of HIV-1 Protease and a Drug-Resistant Mutant in Solution by Nuclear Magnetic Resonance.
|
Academic Article
|
Assembly of human C-terminal binding protein (CtBP) into tetramers.
|
Academic Article
|
Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.
|
Academic Article
|
HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites.
|
Academic Article
|
Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA.
|
Academic Article
|
Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease.
|
Academic Article
|
Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors.
|
Academic Article
|
APOBEC3s: DNA-editing human cytidine deaminases.
|
Academic Article
|
NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations.
|
Academic Article
|
Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance.
|
Academic Article
|
Target-Specific Prediction of Ligand Affinity with Structure-Based Interaction Fingerprints.
|
Academic Article
|
Molecular Determinants of Epistasis in HIV-1 Protease: Elucidating the Interdependence of L89V and L90M Mutations in Resistance.
|
Academic Article
|
Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA.
|
Academic Article
|
Molecular and Structural Mechanism of Pan-Genotypic HCV NS3/4A Protease Inhibition by Glecaprevir.
|
Academic Article
|
Characterizing Protein-Ligand Binding Using Atomistic Simulation and Machine Learning: Application to Drug Resistance in HIV-1 Protease.
|
Academic Article
|
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.
|
Academic Article
|
Crystal Structure of a Soluble APOBEC3G Variant Suggests ssDNA to Bind in a Channel that Extends between the Two Domains.
|
Academic Article
|
Cryo-EM structure of CtBP2 confirms tetrameric architecture.
|
Academic Article
|
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.
|
Academic Article
|
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188.
|
Academic Article
|
NAD(H) phosphates mediate tetramer assembly of human C-terminal binding protein (CtBP).
|
Academic Article
|
Inhibiting HTLV-1 Protease: A Viable Antiviral Target.
|
Academic Article
|
Introduction: Drug Resistance.
|
Academic Article
|
Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s.
|
Academic Article
|
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.
|
Academic Article
|
Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants.
|
Academic Article
|
Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.
|
Concept
|
Protein Domains
|
Concept
|
T-Lymphoma Invasion and Metastasis-inducing Protein 1
|
Academic Article
|
Elucidating the Substrate Envelope of Enterovirus 68-3C Protease: Structural Basis of Specificity and Potential Resistance.
|
Academic Article
|
Direct delivery of Cas-embedded cytosine base editors as ribonucleoprotein complexes for efficient and accurate editing of clinically relevant targets.
|
Academic Article
|
Structural Analysis of Inhibitor Binding to Enterovirus-D68 3C Protease.
|